July 11, 2022 – Judge Daniel D. Crabtree has granted final approval to the $264 million settlement between Plaintiffs and the Mylan Defendants in In re: EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL No. 2785, finding the settlement to …
March 1, 2022 – Plaintiffs in In re: EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL No. 2785, have reached a $264 million settlement with the Mylan Defendants to resolve class claims that Mylan, together with the Pfizer Defendants, engaged …
Plaintiffs Reach Settlement with the Mylan Defendants in EpiPen Class Action Read More »
November 17, 2021 – Today, Judge Daniel D. Crabtree granted final approval of the settlement between Plaintiffs and the Pfizer Defendants in In re: EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL No. 2785, proceeding in the United States District …
June 21, 2021 – In a ground-breaking, unanimous decision, the United States Supreme Court affirmed Northern District of California Judge Claudia Wilken’s determination following a bench trial that NCAA limits on education-related benefits were unreasonable restraints of trade under antitrust law and …
December 18, 2020 – Pritzker Levine is pleased to announce that Judge Christopher C. Conner of the Middle District of Pennsylvania granted final approval to a $15 million antitrust class settlement on behalf of a multi-state class of indirect purchasers …
Final Settlement Approval Granted in ADP v. Viega LLC Antitrust Litigation Read More »